Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2014 · 10-Q
Revenue—
Net Income$64.00K$64.00KN/M vs Q1 2013 EPS Diluted$0.00$0.00— vs Q1 2013 Operating Income$63,000N/M Operating Cash Flow$27,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 12, 2014 · 42 d after period end